Electronic patient diaries and questionnaires ePRO now delivering on the promise?

Patient

Volumn 3, Issue 3, 2010, Pages 179-183

  Tiplady, Brian ^a,b  

^a PRO Consulting   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

outcome assessment (health care); quality of life

Indexed keywords

INFORMATION PROCESSING; INTERACTIVE VOICE RESPONSE SYSTEM; MEDICAL INFORMATICS; MICROCOMPUTER; NOTE; PATIENT ATTITUDE; PERSONAL DIGITAL ASSISTANT; PRIORITY JOURNAL; QUALITY OF LIFE; SYMPTOM; TELEPHONE;

EID: 77954149018     PISSN: 11781653     EISSN: 11781661     Source Type: Journal    
DOI: 10.2165/11537600-000000000-00000     Document Type: Note

References (21)

1. Stone AA, Broderick JE, Shiffman SS, et al. Understanding recall of weekly pain from a momentary assessment perspective: absolute agreement, between- and within-person consistency, and judged change in weekly pain. Pain 2004; 107: 61-69
2. Stull DE, Leidy NK, Parasuraman B, et al. Optimal recall periods for patient-reported outcomes: challenges and potential solutions. Curr Med Res Opin 2009; 25: 929-942
3. Stone AA, Shiffman S, Schwartz JE, et al. Patient noncompliance with paper diaries. BMJ 2002; 324: 1193-1194
4. US Food and Drug Administration. Guidance for industry: patient-reported outcome measures. Use in medical product development to support labeling claims. Washington, DC: US Department of Health and Human Services, 2009
5. McKenzie S, Paty J, Rosano M, et al. Trial power: how eDiary data can enhance the power and reduce the sample size in clinical trials. Appl Clin Trials 2004; 13: 54-68
6. Ganser A, Raymond S, Pearson J. Data quality and power in clinical trials: a comparison of ePRO and paper in a randomized trial. In: Byrom B, Tiplady B, editors. ePRO: electronic solutions for patient reported data. Farnham: Gower. In Press
7. Bernhard J, Cella DF, Coates AS, et al. Missing quality of life data in cancer clinical trials: serious problems and challenges. Stat Med 1998; 17: 517-532
8. Jerndal P, Garn T, Palmblad M, et al. The symptom relieving effect of omeprazole 20 mg b.i.d versus placebo in patients presenting with functional dyspepsia [Data collection report no. SH-OMD-0003-1]. Mölndal: Astra Hässle (now AstraZeneca), 1996 (Data on file)
9. Tiplady B, Crompton GK, Dewar MH, et al. The use of electronic diaries in respiratory studies. Drug Inf J 1997; 31: 759-764
10. Palmblad M, Tiplady B. Electronic diaries and questionnaires: designing user interfaces that are easy for all patients to use. Qual Life Res 2004; 13: 1199-1207
11. Nyholm D, Kowalski J, Aquilonius SM. Wireless real-time electronic data capture for self-assessment of motor function and quality of life in Parkinson's disease. Mov Disord 2004; 19: 446-451
12. Pierce J, Tiplady B. PDA or IVR based patient-reported outcomes systems: criteria to be considered when selecting an electronic PRO technology [white paper]. Pittsburgh (PA): invivodata-, 2009 [online]. Available from URL: http://www.invivodata.com/epro-resources/epro-technologyoptions/ [Accessed 2010 Jan 21]
13. Shields A, Gwaltney C, Tiplady B, et al. Grasping the FDA's PRO guidance. Appl Clin Trials 2006; 15: 69-72
14. Coons SJ, Gwaltney CJ, Hays RD, et al. Recommendations on evidence needed to support measurement equivalence between electronic and paper-based patient-reported outcome (PRO) measures: ISPOR ePRO Good Research Practices Task Force Report. Value Health 2009; 12: 419-429
15. Gwaltney CJ, Shields AL, Shiffman S. Equivalence of electronic and paper-and-pencil administration of patientreported outcome measures: a meta-analytic review. Value Health 2008; 11: 322-333
16. Lundy JJ, Coons SJ. Testing the measurement equivalence of interactive voice response (IVR) and paper versions of the EQ-5D. Poster presented at the International Society for Pharmacoeconomics and Outcomes Research 11th Annual European Congress; 2008 Nov 8-11; Athens
17. Fries JF, Cella D, Rose M, et al. Progress in assessing physical function in arthritis: PROMIS short forms and computerized adaptive testing. J Rheumatol 2009; 36: 2061-2066
18. Solomon KD, Donnenfeld ED, Raizman M, et al. Safety and efficacy of ketorolac tromethamine 0.4% ophthalmic solution in post-photorefractive keratectomy patients. J Cataract Refract Surg 2004; 30: 1653-1660
19. Krystal AD, Walsh JK, Laska E, et al. Sustained efficacy of eszopiclone over 6 months of nightly treatment: results of a randomized, double-blind, placebo-controlled study in adults with chronic insomnia. Sleep 2003; 26: 793-799
20. Clauw DJ, Mease P, Palmer RH, et al. Milnacipran for the treatment of fibromyalgia in adults: a 15-week, multicenter, randomized, double-blind, placebo-controlled, multipledose clinical trial. Clin Ther 2008; 30: 1988-2004
21. Climara Pro ® prescribing information [online]. Available from URL: http://dailymed.nlm.nih.gov/dailymed/drugInfo. cfm?id=10549#nlm34076-0 [Accessed 2010 May 5]